Alkermes Launches 7th Annual Pathways Research Awards Program
Alkermes plc (Nasdaq: ALKS) is excited to announce the start of its seventh annual Alkermes Pathways Research Awards program. This initiative is designed to support emerging researchers striving to enhance our knowledge of psychiatric conditions, especially schizophrenia and bipolar disorder. The application process will begin soon.
Overview of the Pathways Research Awards Program
The Alkermes Pathways Research Awards operate as a competitive grant program, offering individual grants of up to $100,000 for each project. This year's application period will run from late September until the end of November, providing plenty of time for interested researchers to submit their proposals.
Who Can Apply for the Awards?
To qualify for these prestigious grants, applicants need to be early-career investigators, including individuals with M.D.s, Ph.D.s, or similar credentials. Applicants should be within five years of their first academic appointment or currently in post-doctoral fellowships. While the program mainly supports researchers connected to medical or research institutions, it is also dedicated to empowering those who show a strong passion for psychiatric research.
Significance of the Awards Program
Since its launch in 2018, the Pathways program has awarded around $2.5 million in total funding to 25 researchers. Many recipients have successfully published their research in reputable journals and presented their findings at various conferences, showcasing the program's crucial role in advancing innovative neuroscience research.
Insights from Alkermes Leadership
Craig Hopkinson, M.D., who serves as Chief Medical Officer and Executive Vice President of Research and Development at Alkermes, shared his thoughts on the program's mission. "The Alkermes Pathways Research Awards program highlights our commitment to neuroscience. We're looking forward to seeing how grantees will delve deeper into complex psychiatric disorders, significantly contributing to this important field of study," he noted.
Notable Success Stories from Past Recipients
In the past six years, many award winners have made remarkable contributions to neuroscience, conducting significant research that often lays the groundwork for future investigations. Some grantees have even leveraged their Pathways-funded projects to attract additional funding from other esteemed organizations.
How to Submit an Application for the Awards
Researchers who wish to apply for the 2024 Alkermes Pathways Research Awards should visit the dedicated application page. This page will contain detailed information on eligibility criteria, application processes, and important deadlines.
Alkermes’ Commitment to Advancing Neuroscience
Alkermes is committed to creating innovative therapies in the neuroscience domain. The company prides itself on a portfolio of products that tackle significant issues like alcohol and opioid dependence, as well as psychiatric disorders such as schizophrenia and bipolar I disorder. With a robust pipeline of early and late-stage candidates in development, Alkermes is dedicated to advancing scientific research aimed at achieving better health outcomes.
About Alkermes plc
Headquartered in Ireland, Alkermes plc is a global biopharmaceutical company focused on innovation within the neuroscience field. The company also has operational facilities in Massachusetts and Ohio, enhancing its research and manufacturing capabilities.
Frequently Asked Questions
What is the Alkermes Pathways Research Awards program?
This program offers grants to early-career researchers focused on schizophrenia and bipolar disorder, fostering advancements in neuroscience.
How much funding is available through the program?
Each grant can be up to $100,000, supporting various research projects within the neuroscience sector.
Who qualifies to apply for the research awards?
Eligible applicants include M.D.s, Ph.D.s, and post-doctoral fellows affiliated with medical or research institutions, generally within five years of their first academic position.
What has been the program's impact so far?
Since its inception, the program has awarded about $2.5 million, enabling research that often leads to publications and advancements in understanding mental health.
How can researchers express their interest in applying?
Those interested should visit the official Alkermes Pathways Research Awards website for comprehensive information regarding application procedures and eligibility requirements.
